Genetic risk scores in lipid disorders

Curr Opin Cardiol. 2019 Jul;34(4):406-412. doi: 10.1097/HCO.0000000000000623.

Abstract

Purpose of review: Extensive work has gone into understanding the genetics of cardiovascular disease (CVD) and implicating genes involved in hyperlipidaemia. Translation into routine practise involves using genetic risk scores (GRS) to identify high-risk individuals in the general population. Some of these risk scores are beginning to disentangle the complex nature of CVD and inherited dyslipidaemias.

Recent findings: GRS of varying complexity have been used to identify high-risk groups of patients with polygenic CVD including some individuals with risk equivalent to monogenic disease. In phenotypic familial hypercholesterolaemia a six or 12 gene lipid GRS may identify polygenic cases that comprise up to 50% of cases. In high triglyceride syndromes including even cases of familial chylomicronaemia syndrome more than 80% of cases are polygenic and not even associated with rare variants. In both familial hypercholesterolaemia and familial chylomicronaemia syndrome individuals with polygenic disease have a lower risk than those with monogenic disease.

Summary: GRS show promise in identifying individuals with high risks of CVD. They have a close relationship with imaging markers. It is unclear whether GRS, imaging or both will be used to identify individuals at high risk of future events.

Publication types

  • Review

MeSH terms

  • Genetic Predisposition to Disease
  • Humans
  • Lipid Metabolism Disorders / genetics*
  • Risk Factors
  • Triglycerides

Substances

  • Triglycerides